Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Armada Berjaya Trans Tbk (JAYA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Armada Berjaya Trans TbkTrade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Armada Berjaya Trans Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Armada Berjaya Trans Tbk trades at Rp156 (market cap 132.55B, 5.84M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Armada Berjaya Trans Tbk is the larger of the two by market cap. Which is the better fit depends on your goals.

JAYASCPI
Market Cap
132.55B104.4B
Volume
5.84M
Lot
58.43K
Turnover
920.63M
Average Price
157.56
Value
920.63M
Indicative Equilibrium Price
156
Indicative Equilibrium Volume
2.02K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JAYA
View details
SCPI
View details

About Armada Berjaya Trans Tbk

PT Armada Berjaya Trans (“the Entity”) was established based on the Notarial Deed No. 41 dated May 30, 2012 of Myra Yuwono, S.H. The Articles of Assocation has been amended several times, and the latest changes are stated in the Notarial Deed of Christina Dwi Utami, S.H. No. 39 dated August 21, 2018, concerning in the change in the Entity’s name from PT Armada Beton to PT Armada Berjaya Trans. PT Armada Beton specialising in Cement Mixer transporter. Since 2015 the company shifted its focus into general land transport business.

Read more on JAYA

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI